|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
increases activity multiple interactions |
EXP |
artemisinin results in increased activity of NR1I3 protein; artemisinin results in increased activity of NR1I3 protein alternative form; artemisinin results in increased activity of NR1I3 protein mutant form androstan-3-ol inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form]; artemisinin inhibits the reaction [androstan-3-ol results in decreased activity of NR1I3 protein alternative form]; artemisinin inhibits the reaction [Imidazoles results in decreased activity of NR1I3 protein alternative form]; Imidazoles inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form] |
CTD |
PMID:21778469 PMID:27732639 |
|
NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
|
|
|
G |
HSP70 |
heat shock protein 70 |
increases expression multiple interactions |
EXP |
arsenite results in increased expression of HSP70 mRNA HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]] |
CTD |
PMID:32899721 |
|
NCBI chr12:1,285,282...1,287,670
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
arsenite affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]] |
CTD |
PMID:32899721 |
|
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]] |
CTD |
PMID:32899721 |
|
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
arsenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]] |
CTD |
PMID:32899721 |
|
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; HSP70 protein affects the reaction [arsenite inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] |
CTD |
PMID:32899721 |
|
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
EXP |
Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP3 protein] |
CTD |
PMID:25446497 |
|
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
|
|
G |
CASP9 |
caspase 9 |
increases activity multiple interactions |
EXP |
Calcium Oxalate results in increased activity of CASP9 protein Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein] |
CTD |
PMID:25446497 |
|
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
|
|
G |
TJP1 |
tight junction protein 1 |
multiple interactions decreases expression |
EXP |
Phalloidine inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein] |
CTD |
PMID:34147488 |
|
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
|
|
|
G |
CLDN4 |
claudin 4 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] |
CTD |
PMID:23816505 |
|
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:23816505 |
|
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
EXP |
Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:23816505 |
|
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
EXP |
Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:23816505 |
|
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:23816505 |
|
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions decreases activity |
EXP |
Dihydrotestosterone promotes the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein] |
CTD |
PMID:16682413 |
|
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
|
|
|
G |
SCT |
secretin |
increases abundance multiple interactions |
EXP |
SCT protein results in increased abundance of Bicarbonates [Ceruletide co-treated with SCT protein] results in increased abundance of Bicarbonates; Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates] |
CTD |
PMID:3562434 |
|
|
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
EXP |
Dipyrone results in decreased activity of PTGS1 protein alternative form |
CTD |
PMID:12242329 |
|
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
|
|
|
G |
KNG1 |
kininogen 1 |
increases activity |
EXP |
Nitric Oxide deficiency results in increased activity of KNG1 protein modified form |
CTD |
PMID:10805402 |
|
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
|
|
G |
WT1 |
WT1 transcription factor |
multiple interactions |
EXP |
[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased expression of WT1 mRNA |
CTD |
PMID:21443142 |
|
NCBI chr18:35,099,660...35,148,767
Ensembl chr18:35,103,934...35,148,000
|
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
decreases expression |
EXP |
pitavastatin results in decreased expression of NCF1 mRNA |
CTD |
PMID:15502390 |
|
NCBI chr 6:5,702,222...5,719,515
Ensembl chr 6:5,605,694...5,719,458
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases activity increases expression |
EXP |
pitavastatin results in increased activity of NOS3 protein pitavastatin results in increased expression of NOS3 mRNA |
CTD |
PMID:15502390 |
|
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
|
|
G |
NOX4 |
NADPH oxidase 4 |
decreases expression |
EXP |
pitavastatin results in decreased expression of NOX4 mRNA |
CTD |
PMID:15502390 |
|
NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
|
|